{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T07:37:32Z","timestamp":1763105852404},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,4]]},"DOI":"10.7759\/cureus.22855","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T22:20:28Z","timestamp":1646432428000},"source":"Crossref","is-referenced-by-count":1,"title":["Capecitabine-Induced Enterocolitis"],"prefix":"10.7759","author":[{"given":"Muzammil","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kleyner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadia","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda N","year":"2017","unstructured":"Masuda N, Lee S-J, Ohtani S, et al.. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017, 376:2147-59. 10.1056\/NEJMoa1612645","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043116","article-title":"Capecitabine as adjuvant treatment for stage III colon cancer","volume":"352","author":"Twelves C","year":"2005","unstructured":"Twelves C, Wong A, Nowacki MP, et al.. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005, 352:2696-704. 10.1056\/NEJMoa043116","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(98)00058-6","article-title":"Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue","volume":"34","author":"Miwa M","year":"1998","unstructured":"Miwa M, Ura M, Nishida M, et al.. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer. 1998, 34:1274-1281. 10.1016\/S0959-8049(98)00058-6","journal-title":"Eur J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley DB","year":"2003","unstructured":"Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer. 2003, 3:330-8. 10.1038\/nrc1074","journal-title":"Nat Rev Cancer"},{"key":"ref5","unstructured":"Capecitabine tablet, film coated. (2022). Accessed. March 3, 2022: https:\/\/dailymed.nlm.nih.gov\/dailymed\/lookup.cfm?setid=7b260da3-dee2-4bbb-9235-39b16720d578."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/1120009X.2021.2025316","article-title":"Capecitabine-associated enterocolitis: narrative literature review of a rare adverse event and a case presentation","author":"Trontzas IP","year":"2022","unstructured":"Trontzas IP, Rapti VE, Syrigos NK, Gomatou G, Lagou S, Kanellis G, Kotteas EA. Capecitabine-associated enterocolitis: narrative literature review of a rare adverse event and a case presentation. J Chemother. 2022, 10.1080\/1120009X.2021.2025316","journal-title":"J Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-005-0753-2","article-title":"Capecitabine-induced pancolitis","volume":"22","author":"Alexandrescu DT","year":"2007","unstructured":"Alexandrescu DT, Dutcher JP, Wiernik PH. Capecitabine-induced pancolitis. Int J Colorectal Dis. 2007, 22:455. 10.1007\/s00384-005-0753-2","journal-title":"Int J Colorectal Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.11.076","article-title":"Capecitabine-induced enteritis leading to small bowel obstruction","volume":"156","author":"Pow-anpongkul P","year":"2019","unstructured":"Pow-anpongkul P, Chu PG, Kidambi TD. Capecitabine-induced enteritis leading to small bowel obstruction. Gastroenterology. 2019, 156:e8-9. 10.1053\/j.gastro.2018.11.076","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.8.1076.32870","article-title":"Capecitabine-induced pancreatitis","volume":"23","author":"Jones KL","year":"2003","unstructured":"Jones KL, Valero V. Capecitabine-induced pancreatitis. Pharmacotherapy. 2003, 23:1076-8. 10.1592\/phco.23.8.1076.32870","journal-title":"Pharmacotherapy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1186","article-title":"A case of pneumatosis intestinalis with pneumoperitoneum as a potential delayed adverse effect of capecitabine","volume":"10","author":"Khan T","year":"2019","unstructured":"Khan T, Mujtaba M, Flores MS, Nahum K, Carson MP. A case of pneumatosis intestinalis with pneumoperitoneum as a potential delayed adverse effect of capecitabine. World J Oncol. 2019, 10:151-2. 10.14740\/wjon1186","journal-title":"World J Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn397","article-title":"Large bowel perforation associated with capecitabine treatment for breast cancer","volume":"19","author":"Cowman S","year":"2008","unstructured":"Cowman S, Stebbing J, Tuthill M. Large bowel perforation associated with capecitabine treatment for breast cancer. Ann Oncol. 2008, 19:1510-11. 10.1093\/annonc\/mdn397","journal-title":"Ann Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.14621","article-title":"Capecitabine-induced terminal ileitis: case report and literature review","volume":"13","author":"Klimko A","year":"2021","unstructured":"Klimko A, Tieranu CG, Olteanu AO, Preda CM, Ionescu EM. Capecitabine-induced terminal ileitis: case report and literature review. Cureus. 2021, 13:e14621. 10.7759\/cureus.14621","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198106000-00009","article-title":"Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride)","volume":"3","author":"Page JG","year":"1981","unstructured":"Page JG, Dirnberger GM. Treatment of the irritable bowel syndrome with Bentyl (dicyclomine hydrochloride). J Clin Gastroenterol. 1981, 3:153-6. 10.1097\/00004836-198106000-00009","journal-title":"J Clin Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X09104794","article-title":"The treatment of irritable bowel syndrome","volume":"2","author":"Lacy BE","year":"2009","unstructured":"Lacy BE, Weiser K, De Lee R. The treatment of irritable bowel syndrome. Therap Adv Gastroenterol. 2009, 2:221-38. 10.1177\/1756283X09104794","journal-title":"Therap Adv Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-011-1669-x","article-title":"5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity","volume":"69","author":"Jensen SA","year":"2012","unstructured":"Jensen SA, S\u00f8rensen JB. 5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity. Cancer Chemother Pharmacol. 2012, 69:57-64. 10.1007\/s00280-011-1669-x","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-203647","article-title":"Breast cancer, DPYD mutations and capecitabine-related ileitis: description of two cases and a review of the literature","volume":"2014","author":"Mokrim M","year":"2014","unstructured":"Mokrim M, Aftimos PG, Errihani H, Piccart-Gebhart M. Breast cancer, DPYD mutations and capecitabine-related ileitis: description of two cases and a review of the literature. BMJ Case Rep. 2014, 2014:bcr2014203647. 10.1136\/bcr-2014-203647","journal-title":"BMJ Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2019.02.022","article-title":"Cytomegalovirus enterocolitis in a patient with dihydropyrimidine dehydrogenase deficiency after capecitabine treatment: a case report","volume":"56","author":"Inoue F","year":"2019","unstructured":"Inoue F, Yano T, Nakahara M, Okuda H, Amano H, Yonehara S, Noriyuki T. Cytomegalovirus enterocolitis in a patient with dihydropyrimidine dehydrogenase deficiency after capecitabine treatment: a case report. Int J Surg Case Rep. 2019, 56:55-8. 10.1016\/j.ijscr.2019.02.022","journal-title":"Int J Surg Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1159\/000510258","article-title":"Dihydropyrimidine dehydrogenase testing prior to treatment with 5-Fluorouracil, capecitabine, and tegafur: a consensus paper","volume":"43","author":"W\u00f6rmann B","year":"2020","unstructured":"W\u00f6rmann B, Bokemeyer C, Burmeister T, et al.. Dihydropyrimidine dehydrogenase testing prior to treatment with 5-Fluorouracil, capecitabine, and tegafur: a consensus paper. Oncol Res Treat. 2020, 43:628-36. 10.1159\/000510258","journal-title":"Oncol Res Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/88854-capecitabine-induced-enterocolitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:55Z","timestamp":1707507655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/88854-capecitabine-induced-enterocolitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.22855","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,4]]}}}